Bradley Foster & Sargent’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,125
Closed -$906K 371
2019
Q3
$906K Buy
9,125
+451
+5% +$42.9K 0.03% 219
2019
Q2
$802K Sell
8,674
-708
-8% -$67.2K 0.03% 228
2019
Q1
$885K Sell
9,382
-9,281
-50% -$812K 0.03% 217
2018
Q4
$1.2M Sell
18,663
-8,021
-30% -$592K 0.05% 189
2018
Q3
$2.39M Sell
26,684
-4
-0% -$353 0.08% 156
2018
Q2
$2.12M Sell
26,688
-26,407
-50% -$2.19M 0.08% 164
2018
Q1
$4.74M Sell
53,095
-4,924
-8% -$473K 0.18% 105
2017
Q4
$6.05M Sell
58,019
-5,603
-9% -$632K 0.22% 97
2017
Q3
$9.28M Sell
63,622
-52
-0.1% -$7.08K 0.35% 79
2017
Q2
$8.27M Sell
63,674
-5,956
-9% -$730K 0.33% 80
2017
Q1
$8.66M Sell
69,630
-3,126
-4% -$374K 0.35% 82
2016
Q4
$8.42M Buy
72,756
+65
+0.1% +$7.24K 0.36% 81
2016
Q3
$7.6M Sell
72,691
-1,412
-2% -$153K 0.33% 81
2016
Q2
$7.31M Sell
74,103
-13,670
-16% -$1.41M 0.33% 82
2016
Q1
$8.79M Sell
87,773
-12,273
-12% -$1.26M 0.41% 75
2015
Q4
$12M Sell
100,046
-2,001
-2% -$232K 0.55% 63
2015
Q3
$11M Sell
102,047
-1,105
-1% -$137K 0.54% 62
2015
Q2
$11.9M Buy
103,152
+299
+0.3% +$34.2K 0.54% 67
2015
Q1
$11.9M Buy
102,853
+15,130
+17% +$1.81M 0.54% 67
2014
Q4
$9.81M Buy
87,723
+7,072
+9% +$746K 0.46% 76
2014
Q3
$7.64M Buy
80,651
+7,472
+10% +$674K 0.36% 84
2014
Q2
$6.29M Buy
73,179
+7,951
+12% +$605K 0.31% 93
2014
Q1
$4.55M Buy
65,228
+13,634
+26% +$1.08M 0.24% 100
2013
Q4
$4.36M Buy
51,594
+11,496
+29% +$910K 0.23% 105
2013
Q3
$3.09M Buy
40,098
+12,148
+43% +$851K 0.18% 114
2013
Q2
$1.64M Buy
+27,950
New +$1.68M 0.1% 133

Other funds holding CELG

Bradley Foster & Sargent's CELG Position: Q4 2019 in Review

Bradley Foster & Sargent sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,125 shares — an estimated $906K sold.

Bradley Foster & Sargent first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $12M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bradley Foster & Sargent reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bradley Foster & Sargent sold 9,125 Celgene Corp shares in Q4 2019, an estimated $906K.
  • Bradley Foster & Sargent first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bradley Foster & Sargent's Celgene Corp position peaked at $12M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bradley Foster & Sargent's 13F filing for Q4 2019, filed 29 Jan 2020.